Early-life PFAS exposure may hinder adolescent bone development
Early-life exposure to per- and polyfluoroalkyl substances (PFAS) may influence how children’s bones develop during adolescence, according to new research published…
Hormonal imbalance and gut microbes linked to cognitive deficits in patients with PitNETs
Pituitary neuroendocrine tumors (PitNETs) are commonly associated with visual disturbances and endocrine abnormalities; however, many patients also experience…
Engineered lettuce may turn injectable GLP-1 therapies into oral pills
Few drugs have entered mainstream awareness as quickly or as dramatically as glucagon-like peptide-1, or GLP-1 receptor agonists.…
Vaginal estrogen therapy is safe for young endometrial cancer survivors, study finds
Despite the increased incidence of endometrial cancer in younger women, there is limited research regarding the safety of…
UCF researcher explores insulin signaling as new target for diabetic neuropathy
Neuropathy – chronic pain, numbness and tingling in the hands and feet – is a challenging fact of…
Hormone fluctuations influence perceived effort during intense workouts
Female sex hormones estrogen and progesterone fluctuate monthly across the menstrual cycle, affecting moods and energy levels. New…
Privacy-focused AI improves screening for rare endocrinological condition
An AI can accurately diagnose a rare endocrinological condition just by analyzing pictures of the back of the…
Combined GLP-1 and GLP-2 treatment appears safe but does not beat placebo for obesity
Can combining two gut hormone pathways unlock better obesity treatments? In the first human trial of dapiglutide, researchers…
Cyborg transplants may advance cell-based therapies for diabetes
A new electronic implant system can help lab‑grown pancreatic cells mature and function properly, potentially providing a basis…
Key protein regulates slow oxytocin release in the brain
The brain does not only communicate through fast electrical impulses; it also relies on slower, more diffuse chemical…
New prevention strategy can reduce deadly ovarian cancer risk by nearly 80%
A prevention strategy developed by Canadian researchers can reduce the risk of the most common and deadly form of ovarian cancer by nearly…
Palbociclib improves progression-free survival in HER2 positive breast cancer
PrECOG, LLC, today announced the publication of final results from the pivotal phase 3 PATINA study in the…